— Know what they know.
Not Investment Advice
Also trades as: 0IV3.L (LSE) · $vol 0M

GERN NASDAQ

Geron Corporation
1W: -10.0% 1M: -18.7% 3M: -33.0% YTD: -4.5% 1Y: -9.3% 3Y: -58.5% 5Y: -6.0%
$1.28
+0.02 (+1.59%)
 
Weekly Expected Move ±8.3%
$1 $1 $1 $1 $2
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 28 · $821.1M mcap · 536M float · 3.43% daily turnover · Short 50% of daily vol

Cash Flow Trends

Operating Cash Flow
-$111M +49.2% ▲
Capital Expenditures
$49K +92.8% ▲
5Y CAGR: -34.3%
Free Cash Flow
-$111M +49.3% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$1M -114.7% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$116M-$142M-$184M-$175M-$86M
Depreciation & Amort.$783K$868K$1M$1M$1M
Stock-Based Comp.$8M$8M$19M$31M$88K
Change in Working Capital$11M$5M$6M-$68M-$69M
Other Non-Cash Items$984K$626K-$10M-$8M$42M
Operating Cash Flow-$96M-$127M-$168M-$219M-$111M
— Investing Activities —
Capital Expenditures-$207K-$431K-$830K-$680K-$49K
Acquisitions (Net)$2M-$1M$179M$0$0
Investment Purchases-$177M-$258M-$476M-$477M-$304M
Investment Sales$250M$321M$296M$372M$412M
Other Investing-$2M$1M-$179M$0$0
Investing Cash Flow$72M$62M-$180M-$106M$107M
— Financing Activities —
Net Debt Issuance$25M$0$30M$35M$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$3M$17M$119M$159M$0
Financing Cash Flow$49M$87M$362M$334M$2M
Net Change in Cash$25M$22M$14M$10M-$1M
Cash End of Period$35M$57M$71M$81M$79M
Free Cash Flow-$96M-$128M-$169M-$219M-$111M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms